Tevogen Bio Holdings Inc —— 财务报表 (NASDAQ:TVGN) | MetaTrader

展开完整图表

新闻

Tevogen Bio Explores Buyout To Boost Generics Platform - Tevogen Bio Holdings (NASDAQ:TVGN)

D. Boral Capital因稀释风险下调Tevogen Bio目标价至2美元

D. Boral Capital lowers Tevogen Bio stock price target to $2 on dilution risk

Tevogen董事会将评估潜在特别现金股息

Tevogen board to evaluate potential special cash dividend

Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Anglogold Ashanti (NYSE:AU), HeartBeam (NASDAQ:BEAT)

贝莱德生物控股收到纳斯达克最低竞价不足通知

Tevogen Bio Holdings receives Nasdaq notice for minimum bid price deficiency

Tevogen announces $9-11 billion valuation for COVID-19 T cell therapy

Tevogen shares EBV treatment forecast with $3.5 billion revenue potential

Tevogen highlights need for SARS-CoV-2 treatments for immunocompromised

Tevogen reports 60% rise in institutional ownership in Q1 2025